Trials / Completed
CompletedNCT00538603
Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Multi-national, randomized, phase III, GCIG Intergroup study comparing pegylated liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in patients with epithelial ovarian cancer in late relapse. (CALYPSO)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pegylated liposomal Doxorubicin (CAELYX) & Carboplatin | Chemotherapy |
| DRUG | Paclitaxel & Carboplatin | Chemotherapy |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2007-10-02
- Last updated
- 2015-12-17
Source: ClinicalTrials.gov record NCT00538603. Inclusion in this directory is not an endorsement.